Literature DB >> 28905866

Anticoagulation therapy: Bivalirudin not superior to heparin in PCI.

Gregory B Lim.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28905866     DOI: 10.1038/nrcardio.2017.142

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  Bivalirudin versus Heparin Monotherapy in Myocardial Infarction.

Authors:  David Erlinge; Elmir Omerovic; Ole Fröbert; Rikard Linder; Mikael Danielewicz; Mehmet Hamid; Eva Swahn; Loghman Henareh; Henrik Wagner; Peter Hårdhammar; Iwar Sjögren; Jason Stewart; Per Grimfjärd; Jens Jensen; Mikael Aasa; Lotta Robertsson; Pontus Lindroos; Jan Haupt; Helena Wikström; Anders Ulvenstam; Pallonji Bhiladvala; Bo Lindvall; Anders Lundin; Tim Tödt; Dan Ioanes; Truls Råmunddal; Thomas Kellerth; Leszek Zagozdzon; Matthias Götberg; Jonas Andersson; Oskar Angerås; Ollie Östlund; Bo Lagerqvist; Claes Held; Lars Wallentin; Fredrik Scherstén; Peter Eriksson; Sasha Koul; Stefan James
Journal:  N Engl J Med       Date:  2017-08-27       Impact factor: 91.245

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.